Qbic Fund
- Company typePrivate
- Founded2012
- HeadquartersGhent, Belgium
- Headcount1–10
- GTM typeB2B
- OfferingServices
Qbic Fund firmographics
Firmographics- Name
- Qbic Fund
- Legal name
- Qbic Venture Partners II and Qbic Venture Partners III
- Website
- https://qbic.fund
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Where Qbic Fund is headquartered
LocationHeadquarters
- HQ city
- Ghent
- HQ country
- Belgium
- HQ region
- Europe
Offices2 records
Markets served
Qbic Fund business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Venture Capital Management: Qbic generates revenue through traditional venture capital fund mechanisms including management fees and carried interest (performance fees) from successful portfolio company exits.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Qbic Fund product offering
Product offeringCore offering
Qbic Fund is an inter-university venture capital fund based in Ghent, Belgium, founded in 2012. It manages three fund vehicles (Qbic I, II, and III) that provide seed and early-stage equity financing to spin-off companies originating from Belgian universities, research institutes, and hospitals. The fund focuses its investments in the Biotech, HealthTech, Software, and Deeptech sectors.
Product overview
Qbic Fund is an inter-university venture capital fund consisting of three investment vehicles (Qbic I, II, and III) that focus on transforming technological breakthroughs from research institutions into sustainable businesses. The fund invests in seed and early-stage companies across four sectors: Biotech, HealthTech, Software, and Deeptech. Qbic I was formed in 2012, Qbic II in 2016, and Qbic III in 2022. The funds support spin-offs from knowledge partners including universities, research institutes, and hospitals.
Differentiator
Problem solved
Functional benefit
Products and services
- Qbic I
Quantifiable outcome
- 32% of portfolio companies have female CEOs
- +2 more outcomes
Companies that use Qbic Fund
Customer profileSegments2 records
Ideal customer profiles1 record
Qbic Fund technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Qbic Fund partnerships and signals
Strategic signalPartnerships
17 partnerships are on record, tiered notable and core.
- Firecell and Accelleran MergernotableTwo Qbic portfolio companies (Firecell and Accelleran) merged to create a comprehensive private 5G solution, backed by €7.9 million investment including from Qbic, Matterwave Ventures, BPI France, and Cogito Capital Partners.
- Ghent University (Universiteit Gent)corePrimary knowledge partner university; source of spin-off companies and research collaboration.
- VUB (Vrije Universiteit Brussel)coreKnowledge partner university and source of spin-off companies.
- University of AntwerpcoreKnowledge partner university contributing to Qbic's startup ecosystem.
- University of Liège (ULiège)coreKnowledge partner university and source of spin-off companies.
- University of HasseltcoreKnowledge partner university contributing to Qbic's startup ecosystem.
- VITOcoreResearch institute and knowledge partner providing technology commercialization opportunities.
- imeccoreResearch institute specializing in nanoelectronics and digital technologies, key source of deeptech spin-offs.
- UZ GentcoreUniversity hospital providing clinical research collaboration and healthcare innovation spin-offs.
- UZ BrusselcoreUniversity hospital contributing to healthcare startup ecosystem.
- UZ AntwerpencoreUniversity hospital providing clinical research and healthcare innovation opportunities.
- CHU de LiègecoreUniversity hospital contributing to healthcare and biotech startup ecosystem in Wallonia.
- Ziekenhuis Oost-Limburg GenkcoreHospital partner contributing to healthcare innovation ecosystem.
- AZ Maria MiddelarescoreHospital partner contributing to healthcare innovation and digital health startups.
- OLV AalstcoreHospital partner in Qbic's knowledge network.
- VITAZcoreHospital partner contributing to healthcare innovation ecosystem.
- Clinique Saint-Luc BougecoreHospital partner contributing to healthcare innovation network.
Scale indicators5 records
Recent moves8 records
Expansion highlights5 records
Qbic Fund competitors and assessment
Company assessmentDirect peers
- Capricorn Partners: Belgium-based independent venture and growth capital firm with strong ties to KU Leuven and other Flemish universities, investing in tech, healthtech and sustainable technologies. Highly comparable in geographic focus, university-spin-off sourcing model and stage to Qbic.
- Newton Biocapital: Belgian life-sciences venture capital fund investing in early-stage biotech and medtech companies emerging from Belgian and European universities. Closely comparable to Qbic's biotech/healthtech vertical and academic spin-off pipeline.
- V-Bio Ventures: Belgian early-stage venture capital firm focused on biotech and biopharma, often co-investing alongside Qbic in Belgian university spin-offs (e.g. Animab). Comparable in stage, sector and academic deal flow.
- Novalis Biotech: Early-stage Belgian venture fund dedicated to life-sciences spin-offs from Ghent University and KU Leuven, with comparable academic-origin mandate and ticket size to Qbic's biotech investments.
- BioGeneration Ventures: Dutch VC firm specializing in early-stage biotech and life-sciences spin-offs from European universities. Comparable in academic spin-off sourcing and seed/Series A biotech focus.
- VIVES (Inter-university Attraction Pole Fund): Belgian inter-university seed fund linked to UCLouvain and other French-speaking universities, investing in deeptech and biotech spin-offs. Directly comparable to Qbic's inter-university VC model and Belgian academic deal-flow thesis.
Broad incumbents
- PMV (ParticipatieMaatschappij Vlaanderen): Flemish regional investment company providing equity and mezzanine to Flemish startups, often co-investing with Qbic. Comparable Belgian/Flemish focus but broader mandate and larger balance sheet.
- Forbion: Pan-European life-sciences VC firm investing across biotech and medtech at seed to growth stages. Comparable to Qbic's healthtech/biotech exposure but operates at much larger fund sizes and broader European scope.
Emerging players
- imec.xpand: Venture fund affiliated with imec (nanoelectronics) investing in semiconductor and deeptech spin-offs. Comparable as a deeptech/semiconductor-focused fund that draws on Belgian research institutes overlapping with Qbic's network.
- Droia Ventures: Belgian specialist biotech VC investing in early-stage oncology and genetic-disease companies. Comparable Belgian base and biotech focus to Qbic, with overlap in seed-stage spin-off investing.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Qbic Fund social profiles
Digital presenceQbic Fund compliance and trust
Trust signalCompliance1 record
Qbic Fund financial estimates
Financial estimateRevenue estimate
Valuation estimate
Qbic Fund leadership team
Management profileNumber of profiles
Qbic Fund funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Qbic Fund M&A and investment
M&A and investmentM&A
Investments61 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Qbic Fund
What does Qbic Fund do?
Qbic Fund is an inter-university venture capital fund based in Ghent, Belgium, founded in 2012. It manages three fund vehicles (Qbic I, II, and III) that provide seed and early-stage equity financing to spin-off companies originating from Belgian universities, research institutes, and hospitals. The fund focuses its investments in the Biotech, HealthTech, Software, and Deeptech sectors.
Is Qbic Fund a public or private company?
Qbic Fund is a private company. It is classified as venture growth investor backed and is currently operating.
When was Qbic Fund founded?
Qbic Fund was founded in 2012. It employs 1 to 10 people.
Where is Qbic Fund based?
Qbic Fund is headquartered in Ghent, Belgium, in the Europe region.
How does Qbic Fund make money?
One revenue line is on record: venture Capital Management.
Who are Qbic Fund's main competitors?
Direct peers on record are Capricorn Partners, Newton Biocapital, V-Bio Ventures, Novalis Biotech, BioGeneration Ventures and VIVES (Inter-university Attraction Pole Fund). Broad incumbents are PMV (ParticipatieMaatschappij Vlaanderen) and Forbion. Emerging players are imec.xpand and Droia Ventures.
Does Qbic Fund have an API?
No public API is recorded for Qbic Fund.